Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity

Eur J Pharm Biopharm. 2013 Feb;83(2):266-74. doi: 10.1016/j.ejpb.2012.09.014. Epub 2012 Oct 23.

Abstract

The aim of this study was to clarify the relationship between the concentration of Pluronic P123/F127 block copolymers and P-glycoprotein (P-gp) inhibitory potency. Modulation of multidrug resistance (MDR) by Pluronic P123/F127 was evaluated in P-gp over-expressing human breast cancer cell line MCF-7/ADR and its non-P-gp over-expressing counterpart MCF-7 cells. Four different probes (known as P-gp substrates) including rhodamine 123 (R-123), rhodamine 6G (R-6G), doxorubicin (DOX), and paclitaxel (PTX) were applied to investigate the impact of Pluronic P123/F127 copolymers with different concentrations on the intracellular accumulation of these probes. Additionally, the intracellular ATP and mitochondrial transmembrane potential in MCF-7/ADR cells were determined over a wide concentration range of Pluronic P123/F127. Furthermore, the endocytic mechanisms of Pluronic micelles were performed. It was suggested that P-gp substrate hydrophobicity and the concentration of P123/F127 copolymers had little impact on P-gp inhibitory activity of Pluronic P123/F127 itself. Intracellular ATP depletion was the main mechanism of Pluronic P123/F127 for P-gp inhibition. In vitro cytotoxicity study was also conducted in order to compare cytotoxic effect among different PTX formulations. It indicated that the IC50 of PTX-loaded Pluronic P123/F127 mixed micelles was 6.3-fold lower than free PTX and 2.3-fold lower than Taxol, respectively. Therefore, Pluronic P123/F127 polymeric micelles could be considered a promising drug delivery system to overcome MDR in cancer therapy.

Keywords: Cellular uptake; Multidrug resistance; P-gp; Pluronic block copolymer; Polymeric micelles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors*
  • Adenosine Triphosphate / metabolism
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism
  • Cell Line, Tumor
  • Chemistry, Pharmaceutical / methods
  • Doxorubicin / administration & dosage
  • Drug Delivery Systems
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm / drug effects
  • Female
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • MCF-7 Cells
  • Membrane Potential, Mitochondrial / drug effects
  • Micelles
  • Paclitaxel / administration & dosage
  • Poloxalene / administration & dosage*
  • Polyethylenes / administration & dosage*
  • Polymers / administration & dosage*
  • Polypropylenes / administration & dosage*
  • Rhodamine 123 / administration & dosage
  • Rhodamines / administration & dosage

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Micelles
  • Polyethylenes
  • Polymers
  • Polypropylenes
  • Rhodamines
  • rhodamine 6G
  • Rhodamine 123
  • pluronic block copolymer P123
  • Doxorubicin
  • Adenosine Triphosphate
  • Poloxalene
  • UCON 50-HB-5100
  • Paclitaxel